Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation.

导出 LinkOut

翻译打印收藏纠错

作者： Hideyuki,Tamai ^[1] ; Naoki,Shingaki ; Tatsuya,Shiraki ; Hiroshi,Tukuda ; Yoshiyuki,Mori ; Kosaku,Moribata ; Shotaro,Enomoto ; Hisanobu,Deguchi ; Kazuki,Ueda ; Izumi,Inoue ; Takao,Maekita ; Mikitaka,Iguchi ; Kimihiko,Yanaoka ; Masashi,Oka ; Masao,Ichinose

作者单位： Second Department of Internal Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama city, Wakayama 641-0012, Japan. ^[1]

DOI 10.1111/j.1872-034X.2011.00879.x

PMID 21951330

发布时间 2022-03-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览94

Hepatology research

2011年41卷12期

1137-44页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation.

Hepatology research

相似文献

Hepatology research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prediction of sustained response to low-dose pegylated interferon alpha-2b plus ribavirin in patients with genotype 1b and high hepatitis C virus level using viral reduction within 2 weeks after therapy initiation.

Hepatology research

相似文献

Hepatology research

相关期刊

检索历史清除